Beacon Financial Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Buy
1,704
+49
+3% +$11.4K 0.22% 24
2026
Q1
$404K Hold
1,655
0.23% 23
2025
Q4
$342K Hold
1,655
0.19% 26
2025
Q3
$307K Hold
1,655
0.18% 28
2025
Q2
$253K Hold
1,655
0.16% 35
2025
Q1
$274K Buy
1,655
+250
+18% +$39.1K 0.19% 31
2024
Q4
$203K Hold
1,405
0.14% 34
2024
Q3
$228K Hold
1,405
0.16% 32
2024
Q2
$205K Sell
1,405
-160
-10% -$23.8K 0.15% 33
2024
Q1
$248K Hold
1,565
0.18% 28
2023
Q4
$245K Sell
1,565
-15
-0.9% -$2.3K 0.19% 31
2023
Q3
$246K Sell
1,580
-66
-4% -$10.9K 0.21% 30
2023
Q2
$272K Sell
1,646
-83
-5% -$13.4K 0.22% 33
2023
Q1
$268K Sell
1,729
-45
-3% -$7.27K 0.23% 30
2022
Q4
$313K Sell
1,774
-45
-2% -$7.77K 0.28% 30
2022
Q3
$297K Sell
1,819
-50
-3% -$8.46K 0.28% 29
2022
Q2
$332K Hold
1,869
0.31% 28
2022
Q1
$331K Sell
1,869
-107
-5% -$18.2K 0.28% 25
2021
Q4
$338K Buy
1,976
+32
+2% +$5.24K 0.29% 26
2021
Q3
$314K Hold
1,944
0.29% 23
2021
Q2
$320K Buy
+1,944
New +$322K 0.27% 24

Other funds holding JNJ

Beacon Financial Strategies's JNJ Position: Q2 2026 in Review

Beacon Financial Strategies increased its Johnson & Johnson (JNJ) stake by 3% in Q2 2026, buying an estimated $11.4K and bringing the position to 1,704 shares worth $433K. The position accounts for 0.22% of the portfolio, ranked #24.

Beacon Financial Strategies first reported a position in JNJ in Q2 2021 and has held it in 21 quarters since. 836 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Beacon Financial Strategies held 1,704 shares of Johnson & Johnson worth $433K as of Q2 2026.
  • Beacon Financial Strategies bought 49 Johnson & Johnson shares in Q2 2026, an estimated $11.4K.
  • Johnson & Johnson made up 0.22% of Beacon Financial Strategies's portfolio in Q2 2026, its #24 holding.
  • Beacon Financial Strategies first reported a position in Johnson & Johnson in Q2 2021 and has held it in 21 quarters since.
  • 836 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Beacon Financial Strategies's 13F filing for Q2 2026, filed 8 Jul 2026.